Lifestyle changes in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis

被引:59
作者
Fernandez, Tiziana [1 ]
Vinuela, Macarena [2 ]
Vidal, Catalina [3 ]
Barrera, Francisco [2 ]
机构
[1] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Fac Med, Dept Ortopedia & Traumatol, Santiago, Chile
关键词
ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; WEIGHT-LOSS; CARDIORESPIRATORY FITNESS; CLINICAL CHARACTERISTICS; AMERICAN ASSOCIATION; SUPERVISED EXERCISE; RESISTANCE EXERCISE; VISCERAL ADIPOSITY; PRACTICE GUIDANCE;
D O I
10.1371/journal.pone.0263931
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Non-alcoholic fatty liver disease is a liver condition that is increasing worldwide and expected to become the number one cause of cirrhosis and hepatocellular carcinoma in the next 5 years. Currently there are no successful or approved pharmacological treatments. Weight loss is the first-line therapy as a 7 to 10% reduction improves steatosis, inflammation, hepatocyte ballooning, and fibrosis. To achieve this, lifestyle interventions including daily exercise and diet must be encouraged. We aimed to assess the effects of diet, exercise, or a combination of both compared to conventional treatment in patients with non-alcoholic fatty liver disease. Methods and finding A literature search was performed in CENTRAL, EMBASE, and PubMed. Randomized controlled trials comparing lifestyle changes with conventional treatment were included, without date restriction. Two authors searched studies according to eligibility criteria, extracted data, and assessed study quality. Subgroup analysis was made by type of intervention, duration of intervention and supervision. We calculated mean differences between the intervention and the control group with their corresponding 95% confidence intervals. Quality of the evidence was assessed using the Cochrane Risk of bias tool. This study is registered in PROSPERO, number CRD42020184241, and checked with the PRISMA checklist. 30 RCTs met the inclusion criteria. Compared to conventional treatment, combined exercise with diet seems to elicit greater reductions in ALT (MD: -13.27 CI 95% -21.39, -5.16), AST (MD: -7.02 CI 95% -11.26, -2.78) and HOMA-IR (MD: -2.07 CI 95% -2.61, -1.46) than diet (ALT MD: -4.48 CI 95% -1.01, -0.21; HOMA-IR MD: -0.61 CI 95% -1.01, -0.21) and exercise (ALT and AST non-significant; HOMA-IR MD = -0.46 CI 95% -0.8, -0.12) alone. Additionally, exercise improved quality of life, cardiorespiratory fitness, and weight (MD: -2.64 CI 95% -5.18, -0.09). Conclusion Lifestyle changes are effective in the treatment of NAFLD. Diet and exercise combined are superior to these interventions alone in improving liver enzymes and HOMA-IR.
引用
收藏
页数:34
相关论文
共 98 条
[1]   RETRACTED: Effect of Moderate-Intensity Aerobic Exercise on Hepatic Fat Content and Visceral Lipids in Hepatic Patients with Diabesity: A Single-Blinded Randomised Controlled Trial (Retracted Article) [J].
Abdelbasset, Walid Kamal ;
Elsayed, Shereen H. ;
Nambi, Gopal ;
Alrawaili, Saud M. ;
Elnegamy, Tamer E. ;
Khalil, Mona A. ;
Tantawy, Sayed A. ;
Soliman, Gaber S. ;
Ibrahim, Ahmed A. ;
Kamel, Dalia M. .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
[2]   Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease A comparative randomized controlled trial [J].
Abdelbasset, Walid Kamal ;
Tantawy, Sayed A. ;
Kamel, Dalia M. ;
Alqahtani, Bader A. ;
Elnegamy, Tamer E. ;
Soliman, Gaber S. ;
Ibrahim, Ahmed A. .
MEDICINE, 2020, 99 (10) :E19471
[3]  
Abdelbasset WK, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014918, 10.1097/md.0000000000014918]
[4]   Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver [J].
Al-Jiffri, O. ;
Al-Sharif, F. M. ;
Abd El-Kader, S. M. ;
Ashmawy, E. M. .
AFRICAN HEALTH SCIENCES, 2013, 13 (03) :667-672
[5]   8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee* .
DIABETES CARE, 2022, 45 :S113-S124
[6]  
Arab A, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.200854
[7]   Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease [J].
Arab, Juan Pablo ;
Arrese, Marco ;
Trauner, Michael .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13, 2018, 13 :321-350
[8]   The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial [J].
Araceli Marin-Alejandre, Bertha ;
Abete, Itziar ;
Cantero, Irene ;
Ignacio Monreal, J. ;
Elorz, Mariana ;
Ignacio Herrero, Jose ;
Benito-Boillos, Alberto ;
Quiroga, Jorge ;
Martinez-Echeverria, Ana ;
Isidro Uriz-Otano, Juan ;
Pilar Huarte-Muniesa, Maria ;
Tur, Josep A. ;
Alfredo Martinez, J. ;
Angeles Zulet, M. .
NUTRIENTS, 2019, 11 (10)
[9]   Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future [J].
Araujo, Ana Ruth ;
Rosso, Natalia ;
Bedogni, Giorgio ;
Tiribelli, Claudio ;
Bellentani, Stefano .
LIVER INTERNATIONAL, 2018, 38 :47-51
[10]   Both Resistance Training and Aerobic Training Reduce Hepatic Fat Content in Type 2 Diabetic Subjects With Nonalcoholic Fatty Liver Disease (the RAED2 Randomized Trial) [J].
Bacchi, Elisabetta ;
Negri, Carlo ;
Targher, Giovanni ;
Faccioli, Niccolo ;
Lanza, Massimo ;
Zoppini, Giacomo ;
Zanolin, Elisabetta ;
Schena, Federico ;
Bonora, Enzo ;
Moghetti, Paolo .
HEPATOLOGY, 2013, 58 (04) :1287-1295